• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
World J Gastroenterol. 2007 Feb 28;13(8):1292-4. doi: 10.3748/wjg.v13.i8.1292.
2
[Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].[聚乙二醇化干扰素-α2b和利巴韦林治疗慢性丙型肝炎患者中糖尿病酮症酸中毒和自身免疫性甲状腺炎的发生情况]
Korean J Hepatol. 2010 Jun;16(2):187-91. doi: 10.3350/kjhep.2010.16.2.187.
3
[Diabetes mellitus during interferon therapy].
Enferm Infecc Microbiol Clin. 2008 Feb;26(2):120-1. doi: 10.1157/13115550.
4
Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.慢性丙型肝炎患者接受聚乙二醇干扰素和利巴韦林抗病毒治疗期间的甲状腺功能及超声形态学变化
J Viral Hepat. 2009 Mar;16(3):168-77. doi: 10.1111/j.1365-2893.2008.01059.x. Epub 2008 Oct 17.
5
Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
Am J Gastroenterol. 2001 Feb;96(2):604-5. doi: 10.1111/j.1572-0241.2001.03571.x.
6
Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.聚乙二醇化干扰素α治疗期间突发糖尿病酮症酸中毒。
Am J Med. 2003 Aug 1;115(2):158-9. doi: 10.1016/s0002-9343(03)00301-2.
7
Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.聚乙二醇干扰素-α-2b 和利巴韦林治疗慢性丙型肝炎儿童的一过性甲状腺功能减退症和自身免疫性甲状腺炎。
Pediatr Infect Dis J. 2018 Apr;37(4):287-291. doi: 10.1097/INF.0000000000001791.
8
Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C.
Indian J Gastroenterol. 2004 Jan-Feb;23(1):28-9.
9
Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.一名慢性丙型肝炎患者在接受α-干扰素治疗期间发生胰岛素依赖型糖尿病。
Eur J Gastroenterol Hepatol. 2001 Mar;13(3):295-8. doi: 10.1097/00042737-200103000-00015.
10
[Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
Med Clin (Barc). 2003 Mar 15;120(9):359. doi: 10.1016/s0025-7753(03)73703-8.

引用本文的文献

1
Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet-Pharmacotherapy Interactions.饮食对药物疗效的影响:生酮饮食与药物治疗相互作用的综合综述
Nutrients. 2024 Apr 19;16(8):1213. doi: 10.3390/nu16081213.
2
A systematic review and meta-analysis of endocrine-related adverse events associated with interferon.干扰素相关内分泌不良事件的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Aug 5;13:949003. doi: 10.3389/fendo.2022.949003. eCollection 2022.
3
Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.糖尿病酮症酸中毒作为成人隐匿性自身免疫性糖尿病的首发表现,在桥本甲状腺炎首发表现为桥本甲状腺毒症的患者中:病例报告。
J Med Case Rep. 2022 Aug 3;16(1):297. doi: 10.1186/s13256-022-03523-3.
4
Interferon therapy in hepatitis C leading to chronic type 1 diabetes.丙型肝炎的干扰素治疗导致慢性1型糖尿病。
World J Gastroenterol. 2015 Jan 7;21(1):233-9. doi: 10.3748/wjg.v21.i1.233.
5
Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations.在器官特异性自身免疫性疾病中血清 I 型干扰素活性增加:临床、影像和血清学关联。
Front Immunol. 2013 Aug 19;4:238. doi: 10.3389/fimmu.2013.00238. eCollection 2013.
6
Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review.聚乙二醇化干扰素-α联合利巴韦林治疗慢性丙型肝炎相关的1型糖尿病:病例报告及文献综述
Clin Med Insights Endocrinol Diabetes. 2011;4:39-45. doi: 10.4137/CMED.S7815. Epub 2011 Aug 23.
7
Type 1 diabetes caused by interferon alpha-2alpha in polycythemia vera therapy.真性红细胞增多症治疗中α-2α干扰素引起的1型糖尿病。
Diabetes Care. 2010 Nov;33(11):e141. doi: 10.2337/dc10-1266.
8
Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B.一名慢性乙型肝炎患者在接受重组干扰素-α 2b治疗期间突然发生1型糖尿病。
World J Gastroenterol. 2008 Aug 7;14(29):4713-5. doi: 10.3748/wjg.14.4713.

本文引用的文献

1
Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.在聚乙二醇干扰素α-2b联合利巴韦林治疗慢性丙型肝炎期间发生1型糖尿病。
Eur J Gastroenterol Hepatol. 2006 Jun;18(6):689-92. doi: 10.1097/00042737-200606000-00018.
2
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.干扰素-α诱导的甲状腺炎的临床和生理谱:迈向新的分类。
Hepatology. 2006 Apr;43(4):661-72. doi: 10.1002/hep.21146.
3
Prognostic significance of autoimmunity during treatment of melanoma with interferon.黑色素瘤患者接受干扰素治疗期间自身免疫的预后意义
N Engl J Med. 2006 Feb 16;354(7):709-18. doi: 10.1056/NEJMoa053007.
4
[Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].聚乙二醇化干扰素α-2a治疗期间合并Graves病早期并发症的慢性丙型肝炎
Nihon Naika Gakkai Zasshi. 2005 Dec 10;94(12):2600-2. doi: 10.2169/naika.94.2600.
5
Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
Med Princ Pract. 2005 Jul-Aug;14(4):281-3. doi: 10.1159/000085751.
6
Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
J Assoc Physicians India. 2004 Jun;52:514.
7
Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.
Clin Immunol. 2004 Jun;111(3):225-33. doi: 10.1016/j.clim.2004.01.008.
8
[Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].[α-干扰素治疗后针对胰岛细胞抗原的自身抗体与1型糖尿病]
Dtsch Med Wochenschr. 2004 May 14;129(20):1120-4. doi: 10.1055/s-2004-824859.
9
[Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].[慢性丙型肝炎采用α-干扰素和利巴韦林联合治疗期间1型糖尿病的发病情况]
Ugeskr Laeger. 2004 Mar 8;166(11):1024-5.
10
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.慢性丙型肝炎患者在干扰素治疗前后的1型糖尿病。
Aliment Pharmacol Ther. 2003 Sep 15;18(6):549-58. doi: 10.1046/j.1365-2036.2003.01681.x.

Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.

作者信息

Soultati Aspasia S, Dourakis Spyridon P, Alexopoulou Alexandra, Deutsch Melanie, Archimandritis Athanasios J

机构信息

2nd Department of Internal Medicine, University of Athens, Medical School, Hippokration General Hospital, 114 Vas Sofias Avenues, 28 Achaias st, Athens 115 23, Greece.

出版信息

World J Gastroenterol. 2007 Feb 28;13(8):1292-4. doi: 10.3748/wjg.v13.i8.1292.

DOI:10.3748/wjg.v13.i8.1292
PMID:17451219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4147013/
Abstract

Classical interferon-alpha has been shown to be correlated with the development of a variety of autoimmune disorders. A 38 year-old female patient developed simultaneously diabetic ketoacidosis and hyperthyroidism 5 mo following initiation of treatment with pegylated interferon-alpha and ribavirin for chronic hepatitis C. High titers of glutamic acid decarboxylase, antinuclear and thyroid (thyroid peroxidase and thyroglobulin) antibodies were detected. Antiviral treatment was withdrawn and the patient was treated with insulin for insulin-dependent diabetes mellitus and propranolol for hyperthyroidism. Twelve months after cessation of pegylated interferon-alpha therapy the patient was euthyroid without any medication but remained insulin-dependent.

摘要